Quick answer
Insiders filed 3 Form 4 reports showing 9 open-market purchases of InMed Pharmaceuticals Inc. (INM) worth $38,156 between 2026-10-13 and 2026-10-15.
Purchases (Form 4, code P)
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| 2026-10-15 | ADAR1 Capital Management, LLC | 984 | $1.32 | $1,301 |
| 2026-10-15 | ADAR1 Capital Management, LLC | 984 | $1.32 | $1,301 |
| 2026-10-15 | ADAR1 Capital Management, LLC | 984 | $1.32 | $1,301 |
| 2026-10-14 | ADAR1 Capital Management, LLC | 8,021 | $1.33 | $10,668 |
| 2026-10-14 | ADAR1 Capital Management, LLC | 8,021 | $1.33 | $10,668 |
| 2026-10-14 | ADAR1 Capital Management, LLC | 8,021 | $1.33 | $10,668 |
| 2026-10-13 | ADAR1 Capital Management, LLC | 564 | $1.33 | $750 |
| 2026-10-13 | ADAR1 Capital Management, LLC | 564 | $1.33 | $750 |
| 2026-10-13 | ADAR1 Capital Management, LLC | 564 | $1.33 | $750 |
SEC sources
Updated 2026-10-15. Source: SEC EDGAR filings (linked above). Data only. Not investment advice, no buy/sell recommendation.